Insider Transactions in Q2 2023 at Invitae Corp (NVTA)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 13
2023
|
Thomas Brida |
SELL
Open market or private sale
|
Direct |
7,079
-1.0%
|
$7,079
$1.38 P/Share
|
|
Jun 13
2023
|
Robert L Nussbaum Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,086
-1.23%
|
$7,086
$1.38 P/Share
|
|
May 16
2023
|
Kenneth D. Knight Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
45,432
-2.65%
|
$45,432
$1.2 P/Share
|
|
May 16
2023
|
Robert F. Werner Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
21,559
-5.73%
|
$21,559
$1.2 P/Share
|
|
May 16
2023
|
Yafei Wen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
43,452
-5.84%
|
$43,452
$1.99 P/Share
|
|
May 16
2023
|
Robert L Nussbaum Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
26,476
-4.39%
|
$26,476
$1.2 P/Share
|
|
May 16
2023
|
Thomas Brida |
SELL
Open market or private sale
|
Direct |
26,476
-3.59%
|
$26,476
$1.2 P/Share
|
|
Apr 27
2023
|
Randal W. Scott Director |
BUY
Grant, award, or other acquisition
|
Direct |
70,422
+30.4%
|
-
|
|
Apr 27
2023
|
Chitra Nayak Director |
BUY
Grant, award, or other acquisition
|
Direct |
70,422
+38.81%
|
-
|
|
Apr 27
2023
|
Eric Aguiar Director |
BUY
Grant, award, or other acquisition
|
Direct |
70,422
+35.98%
|
-
|
|
Apr 27
2023
|
Christine Marie Gorjanc Director |
BUY
Grant, award, or other acquisition
|
Direct |
70,422
+38.81%
|
-
|
|
Apr 27
2023
|
William H Osborne Director |
BUY
Grant, award, or other acquisition
|
Direct |
88,027
+21.67%
|
-
|
|
Apr 27
2023
|
Kimber D Lockhart Director |
BUY
Grant, award, or other acquisition
|
Direct |
70,422
+38.81%
|
-
|
|
Apr 27
2023
|
Geoffrey Crouse Director |
BUY
Grant, award, or other acquisition
|
Direct |
70,422
+35.09%
|
-
|
|
Apr 03
2023
|
Thomas Brida |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+28.91%
|
-
|
|
Apr 03
2023
|
Yafei Wen Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+28.74%
|
-
|
|
Apr 03
2023
|
Robert F. Werner Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
120,000
+24.42%
|
-
|
|
Apr 03
2023
|
Kenneth D. Knight Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,200,000
+41.14%
|
-
|
|
Apr 03
2023
|
Robert L Nussbaum Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
155,000
+20.45%
|
-
|